About
Technology
Therapeutics
Partnering
Careers
Newsroom
Contact
Twitter
Linkedin
info@bighatbio.com
About
About
Technology
Technology
Therapeutics
Therapeutics
Partnering
Partnering
Careers
Careers
Newsroom
Newsroom
Twitter
Twitter
Linkedin
Linkedin
Contact Us
The Latest
Newsroom
All
Announcements
Press
Publications
Presentations
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
4.24.2024
BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Press
12.5.2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Press
Recent Posts
8.3.2021
BigHat named to Business Insider’s top 24 Biotech startups by leading VCs
Press
7.29.2021
Healthcare finance expert Amol Pawar joins BigHat Advisory team
Announcements
7.28.2021
BigHat publishes research on active learning applied to proteins at the 2021 ICML Workshop on Computational Biology
Announcements
6.29.2021
BigHat CSO and Co-Founder Peyton Greenside recognized as one of Silicon Valley Business Journal’s Women Of Influence for 2021
Announcements
6.17.2021
BigHat Featured on AWS DevOps Blog
Announcements
4.8.2021
BigHat presents at AI for Drug Discovery 2021 conference
Announcements
3.22.2021
BigHat founders discuss AI for Biologics with a16z on Clubhouse
Announcements
3.16.2021
BigHat at WuXi Healthcare Forum 2021
Announcements
3.1.2021
BigHat CSO on the future of machine learning and computational biology at Stanford Computer Science AI Salon
Announcements
2.10.2021
BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments
Announcements
12.14.2020
Antibody developer Steve Doberstein joins BigHat advisory team
Announcements
11.18.2020
Peyton Greenside, BigHat CSO, speaks about machine-guided biological design
Announcements
Previous
3 / 4
Next
© BigHat Bio 2023